BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental Biologics License Application (sBLA) for PALYNZIQ® ...
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q4 2025 Earnings Call Transcript February 17, 2026 Halozyme Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.20327 EPS, expectations ...
Global Pen Needles Market OverviewThe global pen needles market is projected to grow at a robust CAGR of 9% over the next five years. This growth is primarily driven by the rising prevalence of ...
Workstyles are evolving—and so is the PC. Lenovo ThinkBook Auto Twist is Lenovo’s latest innovation, redefining how people interact with their laptops and setting a new benchmark for the convertible ...
As teased earlier today, the Trump administration has announced that the U.S. Environmental Protection Agency is rescinding its 2016 finding that greenhouse gases present a threat to public health.
Five poster presentations highlight clinical advancement of neffy , real-world usability and advantages of needle-free epinephrine ...
Detailed price information for Ars Pharmaceuticals Inc (SPRY-Q) from The Globe and Mail including charting and trades.
The Chicago Auto Show, the nation's longest-running show of its kind, kicks off Saturday at McCormick Place, featuring brand-new experiences and some popular classics. This year's show includes ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. Damian Garde is a reporter at ...
High-level federal officials visited the first public day of the 2026 Detroit Auto Show to tour cars and talk about how the auto industry has changed in the first year of President Donald Trump's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results